• Home
  • TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance.

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance.

Author List
Silwal-Pandit L, Vollan HK, Chin SF, Rueda OM, McKinney S, Osako T, Quigley DA, Kristensen VN, Aparicio S, Børresen-Dale AL, Caldas C, Langerød A
Publication
Clinical cancer research : an official journal of the American Association for Cancer Research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1181837
Publication Year
2014
PubMed ID
24803582
Publication Title
Silwal-Pandit L, Vollan HK, Chin SF, Rueda OM, McKinney S, Osako T, Quigley DA, Kristensen VN, Aparicio S, Børresen-Dale AL, Caldas C, Langerød A. TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance. Clin Cancer Res. 2014 Jul 01; 20(13):3569-80.